Literature DB >> 16769646

Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability.

E M Howgate1, K Rowland Yeo, N J Proctor, G T Tucker, A Rostami-Hodjegan.   

Abstract

The Simcyp Population-Based ADME Simulator was used to predict median drug clearances and their associated variance from in vitro data. Fifteen drugs satisfied the entry criteria for the study and the relevant information (in vitro metabolism data and in vivo human clearance values) were collated from the literature. Predicted values of median clearances fell within 2-fold of observed values for 73% of the drugs (oral route) and 78% of the drugs (intravenous route) when microsomal binding was disregarded, and for 93% (oral) and 100% (intravenous) when it was considered. Irrespective of whether microsomal binding was considered, the predicted fold variability fell within 2-fold of the observed variability for 80% (oral) and 67% (intravenous) of the drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16769646     DOI: 10.1080/00498250600683197

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  64 in total

1.  Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2.

Authors:  David R Plowchalk; Karen Rowland Yeo
Journal:  Eur J Clin Pharmacol       Date:  2012-01-19       Impact factor: 2.953

2.  Evaluating a physiologically based pharmacokinetic model for predicting the pharmacokinetics of midazolam in Chinese after oral administration.

Authors:  Hong-yun Wang; Xia Chen; Ji Jiang; Jun Shi; Pei Hu
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

3.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

4.  Application of CYP3A4 in vitro data to predict clinical drug-drug interactions; predictions of compounds as objects of interaction.

Authors:  Kuresh A Youdim; Aref Zayed; Maurice Dickins; Alex Phipps; Michelle Griffiths; Amanda Darekar; Ruth Hyland; Odette Fahmi; Susan Hurst; David R Plowchalk; Jack Cook; Feng Guo; R Scott Obach
Journal:  Br J Clin Pharmacol       Date:  2008-02-14       Impact factor: 4.335

Review 5.  In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions.

Authors:  Stephen Fowler; Hongjian Zhang
Journal:  AAPS J       Date:  2008-08-07       Impact factor: 4.009

6.  Predictions of metabolic drug-drug interactions using physiologically based modelling: Two cytochrome P450 3A4 substrates coadministered with ketoconazole or verapamil.

Authors:  Nathalie Perdaems; Helene Blasco; Cedric Vinson; Marylore Chenel; Sarah Whalley; Fanny Cazade; François Bouzom
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

7.  Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling.

Authors:  Hannah M Jones; Iain B Gardner; Wendy T Collard; Phil J Stanley; Penny Oxley; Natilie A Hosea; David Plowchalk; Steve Gernhardt; Jing Lin; Maurice Dickins; S Ravi Rahavendran; Barry C Jones; Kenny J Watson; Henry Pertinez; Vikas Kumar; Susan Cole
Journal:  Clin Pharmacokinet       Date:  2011-05       Impact factor: 6.447

8.  Prediction of Metabolic Clearance for Low-Turnover Compounds Using Plated Hepatocytes with Enzyme Activity Correction.

Authors:  Bennett Ma; Roy Eisenhandler; Yuhsin Kuo; Paul Rearden; Ying Li; Peter J Manley; Sheri Smith; Karsten Menzel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-04       Impact factor: 2.441

9.  Identifying populations sensitive to environmental chemicals by simulating toxicokinetic variability.

Authors:  Caroline L Ring; Robert G Pearce; R Woodrow Setzer; Barbara A Wetmore; John F Wambaugh
Journal:  Environ Int       Date:  2017-06-16       Impact factor: 9.621

10.  Incorporation of the Time-Varying Postprandial Increase in Splanchnic Blood Flow into a PBPK Model to Predict the Effect of Food on the Pharmacokinetics of Orally Administered High-Extraction Drugs.

Authors:  Rachel H Rose; David B Turner; Sibylle Neuhoff; Masoud Jamei
Journal:  AAPS J       Date:  2017-05-19       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.